查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球即時檢測的成長機會
市場調查報告書
商品編碼
1395900

全球即時檢測的成長機會

Global Point-of-care Testing Growth Opportunities
出版日期: | 出版商: Frost & Sullivan | 英文 79 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

分子 POCT 釋放分散式診斷資料生態系統的成長潛力

本研究概述了全球即時檢測 (POCT) 產業。 POCT 是指在患者進行治療或手術的地點或附近快速進行的常規或專門的實驗室病理學測試。 COVID-19 的加劇正在改變全球診斷格局。醫療保健環境的整合趨勢、結構性轉變，以及 POCT 擴展到性行為感染(STI)、抗菌素抗藥性 (AMR)、常規檢測、腫瘤學和新生兒篩檢，正在創造新的領域。未來，腫瘤、中風和失智症等治療領域可能會成為 POCT 的一部分。

在新興經濟體，症狀檢測的廣泛普及、免疫檢測中多重檢測的滲透、核酸擴增技術的進步（從 PCR 到等溫擴增）、唾液檢體的使用以及抗菌素抗藥性檢測的進步推動了市場活力的不斷增強。此外，支援人工智慧/機器學習的設備軟體功能以及診斷資料計劃計劃下指定的變更管理計劃正在加速美國的市場機會。

在新興經濟體，多參數平台不斷湧現，以滿足部門和中小型實驗室對 POC 不斷成長的需求。此外，人們對預防醫學的濃厚興趣正在為使用新的血液檢測平台進行常規檢測奠定基礎。

強大的多重生態系統加上診斷資料融合創造新收益流（例如連接和數位醫療技術服務）的潛力，將支持擺脫 COVID-19 測試和改變臨床途徑。對類似測試的適應體現了更大的協調性基於實驗室和非實驗室的診斷資料，以創建更永續的照護端生態系統。

目錄

戰略問題

  • 為什麼成長如此困難？
  • The Strategic Imperative 8（TM）
  • 床邊檢測 (POCT) 產業三大策略重點的影響
  • 成長機會加速Growth Pipeline Engine（TM）

成長機會分析

  • 分析範圍
  • 細分-檢查類型
  • 細分 - 護理連續體
  • 主要競爭
  • 成長指標
  • 生長促進因子
  • 成長抑制因素
  • 預測假設
  • 收益預測
  • 按測試類型分類的收益預測
  • 地區收益預測
  • 按護理連續體分類的收益預測
  • 預測分析
  • 價格趨勢和預測分析
  • 競爭環境
  • POCT在各個治療領域的應用
  • 收益佔有率
  • 收益佔有率分析
  • 競爭矩陣 - 治療領域
  • 競爭矩陣 - 技術映射

生長機會分析 - 免疫化學 POCT

  • 成長指標
  • 收益預測
  • 地區收益預測
  • 免疫化學POCT收益預測
  • 預測分析

成長機會分析 - 分子 POCT

  • 成長指標
  • 收益預測
  • 地區收益預測
  • 分子POCT治療領域收益預測
  • 預測分析

成長機會宇宙

  • 成長機會1：分子POCT
  • 成長機會 2：多重化
  • 成長機會3：STI POCT
  • 成長機會4：AMR POCT
  • 成長機會 5：常規 POCT
  • 成長機會6：智慧型手機POCT
  • POCT 在護理連續體中的未來

下一步

  • 下一步
  • 為什麼是霜凍，為什麼是現在？
  • 附件清單
  • 免責聲明
簡介目錄
Product Code: K973-55

Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.

In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.

In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.

A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation-Test Type
  • Segmentation-Care Continuum
  • Key Competitors
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Test Type
  • Revenue Forecast by Region
  • Revenue Forecast by Care Continuum
  • Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • POCT Across Different Therapy Areas
  • Revenue Share
  • Revenue Share Analysis
  • Competitor Matrix-Therapy Areas
  • Competitor Matrix-Technology Mapping

Growth Opportunity Analysis- Immunochemistry POCT

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Immunochemistry POCT
  • Forecast Analysis

Growth Opportunity Analysis-Molecular POCT

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Molecular POCT Therapy Areas
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: Molecular POCT
  • Growth Opportunity 2: Multiplexing
  • Growth Opportunity 3: STI POCT
  • Growth Opportunity 4: AMR POCT
  • Growth Opportunity 5: Routine POCT
  • Growth Opportunity 6: Smartphone POCT
  • Future of POCT in Care Continuum

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer